Table 2.
Decision |
Decision aid
|
Comparison group
|
Weight | Mean difference (95% CI) | |||
---|---|---|---|---|---|---|---|
No of patients | Mean (SD) conflict score | No of patients | Mean (SD) conflict score | ||||
Compared with usual care | |||||||
Prostate specific antigen test19 | 50 | 1.8 (0.5) | 50 | 2.2 (0.7) | 27.5 | −0.4 (−0.7 to −0.2) | |
Ischaemic heart disease25 | 86 | 2.1 (1.5) | 94 | 2.1 (1.5) | 8.1 | 0.0 (−0.4 to 0.4) | |
Compared with less intensive decision aid | |||||||
Hormone therapy28 | 83 | 2.6 (1.0) | 89 | 3.0 (1.0) | 17.8 | −0.4 (−0.7 to −0.1) | |
Hormone therapy26 | 81 | 2.1 (0.6) | 84 | 2.3 (0.6) | 46.6 | −0.2 (−0.4 to −0.02) | |
Total (fixed effects χ2=3.89 (df =3), Z=4.3) | 300 | 317 | 100 | −0.3 (−0.4 to −0.1) |
Decisional conflict ranges theoretically from 1 (strong agreement that one is certain, informed, clear about values, and supported in decision making) and 5 (strong disagreement). Scores above 2.5 are associated with decision delay and those below 2 are associated with decision implementation. A negative mean difference means the decision aid had a positive benefit.